PEG-BIO Biopharm Co.,Ltd(chongqing).
Home
About Us
Core Technology
Ongoing Projects
Biosimilar Drug Pepline
News Center
Contact Us
News Center
Home
>>
News Center
>>
Industry News
>>
行业动态详情
国内首仿!我司注射用重组替度鲁肽启动Ⅲ期临床
Source:
https://mp.weixin.qq.com/s/V0EJ1buJDmI3O3UGOdS2og
|
Author:
CHEN Chunyou | Science and Technology Daily
|
Published time:
2024-04-23
|
51
Views
|
Share:
近期,我司在CDE临床试验登记与信息公示平台上登记启动了PJ009(注射用重组替度鲁肽)的Ⅲ期临床试验,适应症为短肠综合征(Short Bowel Syndrome,SBS)。
上一篇:
Chengdu-Ch......
下一篇:
None
Company News
Cooperative partner
Industry News